Mol. Cells 2009; 28(5): 489-494
Published online October 21, 2009
https://doi.org/10.1007/s10059-009-0141-9
© The Korean Society for Molecular and Cellular Biology
We have previously shown that the down-regulation of protein kinase CKII activity is tightly associated with cellular senescence of human fibroblast IMR-90 cells. Here, we examined the roles of p53 and p21Cip1/WAF1 in senescence development induced by CKII inhibition using wild-type, isogenic p53-/- and isogenic p21-/- HCT116 human colon cancer cell lines. A senescent marker appeared after staining for senescence-associated β-galactosidase activity in wild-type HCT116 cells treated with CKII inhibitor or CKIIα siRNA, but this response was almost abolished in p53- or p21Cip1/WAF1-null cells. Increased cellular levels of p53 and p21Cip1/WAF1 protein occurred with the inhibition of CKII. CKII inhibition upregulated p53 and p21Cip1/WAF1 expression at post-transcriptional level and transcription level, respec-tively. RB phosphorylation significantly decreased in cells treated with CKII inhibitor. Taken together, this study shows that the activation of the p53-p21Cip1/WAF1 pathway acts as a major mediator of cellular senescence induced by CKII inhibition.
Keywords human colon cancer cell, p21Cip1/WAF1, p53, protein kinase CKII, senescence
Mol. Cells 2009; 28(5): 489-494
Published online November 30, 2009 https://doi.org/10.1007/s10059-009-0141-9
Copyright © The Korean Society for Molecular and Cellular Biology.
Ji-Young Kang, Jin Joo Kim, Seok Young Jang, and Young-Seuk Bae
We have previously shown that the down-regulation of protein kinase CKII activity is tightly associated with cellular senescence of human fibroblast IMR-90 cells. Here, we examined the roles of p53 and p21Cip1/WAF1 in senescence development induced by CKII inhibition using wild-type, isogenic p53-/- and isogenic p21-/- HCT116 human colon cancer cell lines. A senescent marker appeared after staining for senescence-associated β-galactosidase activity in wild-type HCT116 cells treated with CKII inhibitor or CKIIα siRNA, but this response was almost abolished in p53- or p21Cip1/WAF1-null cells. Increased cellular levels of p53 and p21Cip1/WAF1 protein occurred with the inhibition of CKII. CKII inhibition upregulated p53 and p21Cip1/WAF1 expression at post-transcriptional level and transcription level, respec-tively. RB phosphorylation significantly decreased in cells treated with CKII inhibitor. Taken together, this study shows that the activation of the p53-p21Cip1/WAF1 pathway acts as a major mediator of cellular senescence induced by CKII inhibition.
Keywords: human colon cancer cell, p21Cip1/WAF1, p53, protein kinase CKII, senescence
Hyeon Ju Lee, Yu-Jin Jung, Seungkoo Lee, Jong-Il Kim, and Jeong A. Han
Mol. Cells 2020; 43(4): 397-407 https://doi.org/10.14348/molcells.2020.2231Hyungmin Kim, Jeehan Lee, Soon-Young Jung, Hye Hyeon Yun, Jeong-Heon Ko, and Jeong-Hwa Lee
Mol. Cells 2022; 45(10): 718-728 https://doi.org/10.14348/molcells.2022.0037Muhammad Junaid, Aejin Lee, Jaehyung Kim, Tae Jun Park, and Su Bin Lim
Mol. Cells 2022; 45(9): 610-619 https://doi.org/10.14348/molcells.2022.0036